Abstract:Positron emission tomography (PET) and magnetic resonance imaging (MRI) are established imaging modalities for the study of neurological disorders, such as epilepsy, dementia, psychiatric disorders and so on. Since these two available modalities vary in imaging principle and physical performance, each technique has its own advantages and disadvantages over the other. To acquire the mutual complementary information and reinforce each other, there is a need for the fusion of PET and MRI. This combined dual-modality (either sequential or simultaneous) could generate preferable soft tissue contrast of brain tissue, flexible acquisition parameters, and minimized exposure to radiation. The most unique superiority of PET/MRI is mainly manifested in MRI-based improvement for the inherent limitations of PET, such as motion artifacts, partial volume effect (PVE) and invasive procedure in quantitative analysis. Head motion during scanning significantly deteriorates the effective resolution of PET image, especially for the dynamic scan with lengthy time. Hybrid PET/MRI device can offer motion correction (MC) for PET data through MRI information acquired simultaneously. Regarding the PVE associated with limited spatial resolution, the process and reconstruction of PET data can be further optimized by using acquired MRI either sequentially or simultaneously. The quantitative analysis of dynamic PET data mainly relies upon an invasive arterial blood sampling procedure to acquire arterial input function (AIF). An image-derived input function (IDIF) method without the need of arterial cannulization, can serve as a potential alternative estimation of AIF. Compared with using PET data only, combining anatomical or functional information from MRI for improving the accuracy in IDIF approach has been demonstrated. Yet, due to the interference and inherent disparity between the two modalities, these methods for optimizing PET image based on MRI still have many technical challenges. This review discussed upon the most recent progress, current challenges and future directions of MRI-driven PET data optimization for neurological applications, with either sequential or simultaneous acquisition approach.

PET‐MRI Applications and Future Prospects in Psychiatry

Molecular Imaging in Neuroscience Research with Small-Animal PET in Rodents

Molecular imaging in neuroscience research with small-animal PET in rodents.

Molecular imaging in patients with mood disorders: a review of PET findings

The Applications of Positron Emission Tomography in Neurological and Psychiatric Disorders

PET/MRI of Central Nervous System: Current Status and Future Perspective

Progress on the Application of Positron Emission Tomography Imaging of Cannabinoid Type 1 Receptor in Neuropsychiatric Diseases.

MRI-Driven PET Image Optimization for Neurological Applications

PET Brain Imaging in Neurological disorders

The Development, Past Achievements, and Future Directions of Brain PET

PET/fMRI for precise localization of abnormal brain activity: a mini review

The use of PET imaging in studying cognition, genetics and pharmacotherapeutic interventions in schizophrenia

The use of positron emission tomography/magnetic resonance imaging in dementia: A literature review

Brain Molecular Connectivity in Neurodegenerative Diseases: Recent Advances and New Perspectives Using Positron Emission Tomography

Current Applications of PET/MR: Part I: Technical Basics and Preclinical/Clinical Applications

Spatial normalization and quantification approaches of PET imaging for neurological disorders

An outlook on future design of hybrid PET/MRI systems

Translational Multimodality Neuroimaging

Current Applications of PET/MR: Part II: Clinical Applications II

PET/MRI: Where might it replace PET/CT?

The perspectives of neurologists on positron emission tomography utility in multiple sclerosis: a qualitative study